[So-called refractory hypoxemia: treatment with acexamic acid].
Acexamic acid is currently used to avoid pulmonary fibrosis in patients treated with bleomycim. It seems to be equally effective to prevent pulmonary fibrosis in adult respiratory distress syndrome. The complications of this therapy are hypercalcemia and hypernatremia.
D000293:Adolescent; D000328:Adult; D000614:Aminocaproates / Q000627:therapeutic use*; D015119:Aminocaproic Acid / Q000627:therapeutic use*; D001761:Bleomycin / Q000009:adverse effects; D005260:Female; D006801:Humans; D000860:Hypoxia / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011658:Pulmonary Fibrosis / Q000517:prevention & control
D000614:Aminocaproates; D001761:Bleomycin; C018802:6-acetylaminocaproic acid; D015119:Aminocaproic Acid
Hypoxémies dites réfractaires: traitement par acide acéxamique.